Although the regulation of the IFNβ gene has been well characterized, the induction of the large family of IFNα genes has remained obscure. We report that the IFNα genes can be divided into two groups: an immediate-early response gene (IFNα4) which is induced rapidly and without the need for ongoing protein synthesis; and a set of genes that display delayed induction, consisting of at least IFNα2, 5, 6 and 8, which are induced more slowly and require cellular protein synthesis. One protein that must be synthesized for induction of the delayed gene set is IFN itself, presumably IFNα4 or IFNβ, which stimulates the Jak-Stat pathway through the IFN receptor, resulting in activation of the transcription factor interferonstimulated gene factor 3 (ISGF3). Among the IFNstimulated genes induced through this positive feedback loop is the IFN regulatory factor (IRF) protein, IRF7. Induction of IRF7 protein in response to IFN and its subsequent activation by phosphorylation in response to virus-specific signals, involving two C-terminal serine residues, are required for induction of the delayed IFNα gene set.
Introduction
Infection by viruses triggers transcription of a large number of cellular genes, either directly through activation of cellular transcription factors or indirectly through prior induction of type I interferons (IFNα and IFNβ). IFNs synthesized in virus-infected cells are secreted and can act in an autocrine or paracrine manner through binding to a specific cell-surface receptor. IFN binding to the type I receptor stimulates the Jak-Stat signal transduction cascade, leading to induction of IFN target genes responsible for the pleiotropic biological effects of IFN, including antiviral activity.
Signaling from the type I IFN receptor has been 6660 © Oxford University Press elucidated recently (reviewed in Darnell, 1997) . Activation of the cytoplasmic tyrosine protein kinases Jak1 and Tyk2 leads to phosphorylation of Stat1 and Stat2, transcription factors that heterodimerize, translocate to the nucleus and assemble with the DNA-binding protein interferonstimulated gene factor 3γ (ISGF3γ) to form the ISGF3 complex. ISGF3γ (Veals et al., 1992 (Veals et al., , 1993 ) is a member of the IFN regulatory factor (IRF) family (Nguyen et al., 1997) that is characterized by a conserved DNA-binding domain encoding a characteristic DNA sequence preference related to the positive regulatory domain I (PRDI) of the IFNβ promoter (Goodbourn and Maniatis, 1988; Harada et al., 1989; Bluyssen et al., 1996) . The recruitment of Stat1 and Stat2 by ISGF3γ to form ISGF3 provides a distinct DNA recognition specificity to this complex, allowing it to bind with high affinity to the IFN-stimulated response element (ISRE) found in the promoters of IFNstimulated target genes but to bind with significantly lower affinity to the PRDI elements found in IFN promoters (Veals et al., 1993; Yoneyama et al., 1996) . Whereas IFNβ is encoded by a single gene, IFNα is represented by a large family of structurally related genes localized in a cluster on mouse chromosome 4 (Kelley and Pitha, 1985) . More than a dozen IFNα genes have been identified in the mouse and are reported to be coordinately induced in virus-infected cells. However, the primary activation mechanism of these genes by virus infection remains to be elucidated completely. Among the type I IFN genes, activation of IFNβ has been studied most extensively. The virus-inducible enhancer of the IFNβ gene consists of a complex enhancer composed of different positive and negative regulatory elements that bind different, cooperating transcription factors (Kim and Maniatis, 1997) . PRDIV binds a heterodimer of ATF-2 and c-jun, and PRDII binds the inducible transactivator protein NFκB. PRDI and PRDIII are related sequence elements that bind members of the IRF family. Previous data suggested that IRF1 was the relevant activator protein binding to PRDI and PRDIII (Fujita et al., 1988 Reis et al., 1992) . However, these early observations were disputed by the finding that disruption of the IRF1 gene in mice did not impair the induction of IFN gene expression by virus infection (Matsuyama et al., 1993; Reis et al., 1994) . More recent evidence suggests the involvement of other IRF family members, particularly IRF3 Sato et al., 1998; Schafer et al., 1998; Wathelet et al., 1998; Yoneyama et al., 1998) and possibly IRF7 (Wathelet et al., 1998) , in transcriptional induction of IFNβ.
Regulation of the IFNα genes is less well defined. The virus-responsive element in IFNα promoters contains PRDI-like sequences (Näf et al., 1991; Au et al., 1993; Genin et al., 1995; Pitha and Au, 1995; Braganca et al., 1997) , suggesting the involvement of IRF proteins. IRF1 is unlikely to be the factor bound to this site in IFNα promoters (Au et al., 1993; Ruffner et al., 1993) , and thus the identity of the proteins involved in virus-mediated induction of these genes remains unclear. Here, we show that IFNα4 plays a unique role in the IFNα family. Based on the observation that induction of IFNα genes by Newcastle disease virus (NDV) was reduced in the absence of Stat1, we show that IFNα4 is the only species directly induced in response to virus infection. The other species of IFNα were dependent on new protein synthesis for their induction, including the synthesis of IFN itself and of the transcription factor IRF7. In addition, we show that IRF7 requires a virus-specific modification for transcriptional activity, and localize this modification to a phosphorylation event requiring two serine residues near the C-terminus.
Results

Impaired viral induction of IFNα genes in the absence of Stat1
The acute viral sensitivity of Stat1-deficient mice can be at least partially explained by the complete loss of responsiveness to virally induced IFN Meraz et al., 1996) . Virus induction of type I IFN mRNA was observed in Stat1-deficient mice using probes for mouse IFNα4 and IFNβ . To characterize this response in more detail, we compared the magnitude and kinetics of IFN production in cells from wild-type and Stat1-deficient mice. Although production of IFNγ from virus-stimulated T lymphocytes was not significantly affected by the absence of Stat1 (C.K.Lee, R.Gimeno, R.Gertner and D.E.Levy, manuscript in preparation) and IFNβ gene expression was detected in virusinfected fibroblasts (see below), induction of IFNα gene expression was significantly impaired in Stat1 mutant cells ( Figure 1A ). Immortalized mouse embryo fibroblasts (MEFs) from wild-type and Stat1-deficient mice were infected with NDV and RNA was isolated for quantification of IFNα mRNA levels by RT-PCR. While wildtype cells rapidly produced high levels of IFNα in response to virus infection, with high levels produced within 6-8 h ( Figure 1A , lanes 9-12), Stat1-/-cells produced much lower levels of IFNα mRNA and significant accumulation was not detected until 10-12 h ( Figure 1A , lanes 5-6).
The level of IFNα gene induction was quantified by using serial dilution RT-PCR ( Figure 1B) . At 6 h postinfection (p.i.), IFNα mRNA from wild-type cells was readily detected following 125-fold dilution of cDNA ( Figure 1B , lane 4) and at 10 h was detected following 625-fold dilution ( Figure 1B , lane 10). In contrast, IFNα mRNA from Stat1-/-cells was only detected in the undiluted sample 6 h p.i. (Figure 1B , lane 2) and in the 5-fold diluted sample 10 h p.i. (Figure 1B, lane 7) . Therefore, the difference in IFNα induction between wildtype and Stat1-/-cells at peak induction is probably Ͼ100-fold.
Murine IFNα is composed of a mixture of isotypes encoded by a family of highly homologous, linked genes tandemly arrayed on chromosome 4 (De Maeyer and De Maeyer-Guignard, 1988) . The analysis shown in Figure 1 was designed to detect all members of the IFNα family by using primers corresponding to conserved sequences expression derived from sequence analysis, an expression assay was devised that specifically detected all species of IFNα other than IFNα4. PCR primers were designed that excluded IFNα4 amplification due to a 15 nucleotide difference in this isoform relative to other IFNα species (Kelley and Pitha, 1985) . Using this analysis on RNA from virally infected cells, robust gene expression was detected in wild-type cells ( Figure 2A , lanes 10-12), consistent with the results from cDNA cloning. In marked contrast, no IFNα gene expression could be detected from Stat1-/-cells using this assay system, indicating that all the IFNα produced by these cells (see Figure IFNα4. However, the magnitude of IFNα4 expression was reduced in the absence of Stat1. Comparison of IFNα levels 6 h p.i., when essentially no non-IFNα4 gene was expressed in either wild-type or Stat1-/-cells ( Figure 2A , lanes 3 and 9; B, lane 1), showed that~25-fold higher levels of IFNα mRNA were produced by wild-type than by Stat1-/-cells ( Figure 1B ). Stat1 therefore regulates two aspects of IFNα gene expression. First, it influences the abundance of IFNα4 production, and secondly, it is required for expression of all other IFNα subtypes. The Stat1 requirement for expression of the non-IFNα4 subset in wild-type cells could be due to a direct involvement of Stat1 in IFNα gene transcription or to an indirect role secondary to production of a Stat1-dependent intermediate. To investigate this notion, the possible requirement for on-going protein synthesis for the regulation of IFNα species was considered. Wild-type cells were infected with NDV in the presence of cycloheximide (CHX) to block new protein synthesis, and the expression of IFNα was measured ( Figure 2C ). While induction of IFNα4 was only partially reduced in the presence of CHX, no expression of the non-IFNα4 subset was detected in CHX-treated cells (lane 3). Therefore, IFNα4 fits the criteria for an immediate-early response gene while the non-IFNα4 subset consists of delayed-early genes that require on-going protein synthesis and rely on Stat1 for their expression.
The requirement for both Stat1 and protein synthesis for induction of the delayed, non-IFNα4 subset of genes suggested that IFN itself might be involved since Stat1 is known to be activated by IFN. NDV-infected cells produced high concentrations of active type I IFN in culture supernatants and the induction of the non-IFNα4 genes was partially impaired by treatment with anti-IFN antibodies (data not shown). To confirm a requirement for IFN, induction of IFNα gene expression was investigated in cells from type I IFN receptor-deficient mice (IFNAR-/-). The same pattern of IFNα gene expression was observed in NDV-infected IFNAR-/-cells and Stat1-/-cells ( Figure 2D ). Only IFNα4 RNA was detected in infected IFNAR-/-cells while the non-IFNα4 subset was completely absent. In contrast, IFNα production was normal in cells from IFNγ-deficient mice, showing that only type I IFN is required for expression of the non-IFNα4 genes.
Delayed-early IFNα genes require IFN-dependent positive feedback
The similarity in phenotype between IFNAR-/-and Stat1-/-cells suggested that the Stat1 requirement was subsequent to IFN production and that the protein synthesis requirement for IFNα expression might be explained by secretion of IFN. To test this idea, we considered whether exogenously added IFN could replace the requirement for protein synthesis for induction of delayed-early IFN production. Wild-type cells were infected with NDV in the presence of CHX, and type I IFN was added to the culture supernatant ( Figure 2E ). While CHX fully blocked the production of the non-IFNα4 subset ( Figure 2E Figure 2E , lane 6) partially restored the expression of the delayed-early genes, even though IFN treatment alone without subsequent virus infection could not induce the IFN genes in these cells (not shown). Therefore, IFN protein production is at least one of the protein synthetic steps required for expression of non-IFNα4 genes.
Another indication that IFN is involved in the Stat1 requirement for expression of non-IFNα4 genes came from analysis of Stat1 isoforms. Two splice variants of Stat1 are normally expressed and the Stat1β form functions only in type I IFN responses while Stat1α can function in multiple cytokine responses (Müller et al., 1993) . We derived stable cell lines from Stat1-deficient fibroblasts by transfection with cDNA expression constructs for each Stat1 isoform. Infection of cells reconstituted with Stat1α ( Figure 2E , lane 7) or with Stat1β ( Figure 2E , lane 8) were capable of producing non-IFNα4 isoforms. IFNα induction by reconstituted cells did not equal that from wild-type cells ( Figure 2E , compare lanes 7 and 8 with lane 3). However, the level of recombinant Stat1 protein expressed in these cell lines was significantly less than that in wild-type cells (not shown). Taken together, these results strongly suggest that the Stat1 requirement for non-IFNα4 isoform expression is downstream of a response to type I IFN that is mediated by the type I IFN receptor.
Non-IFNα4 genes are induced by IRF7
Exogenous IFN only partially restored expression of non-IFNα4 genes in CHX-treated cells, suggesting that a protein other than IFN was also required to induce these genes. Virus-inducible elements in IFNα gene promoters (Ryals et al., 1985; Au et al., 1993 ) contain sequences similar to the PRDI and PRDIII sequences of the IFNβ promoter known to bind members of the IRF family of transcription factors (Genin et al., 1995; Braganca et al., 1997) . Therefore, we considered whether any IRF family members that are induced by IFN in a Stat1-dependent manner could be involved in induction of the delayedearly IFNα isoforms. cDNA products were amplified using consensus primers based on the conserved DNA-binding region of IRF proteins. A major product detected using RNA from IFN-treated cells that was not detected using control RNA was sequenced and found to be identical to mouse IRF7 (I.Marié, E.Smith, R.Raz, Y.Wang, D.Ray, H.A.R.Bluyssen and D.E.Levy, manuscript in preparation).
IRF7 gene expression was analyzed in wild-type and Stat1-/-cells infected with NDV ( Figure 3A) . For comparison, expression of the related IRF3 gene was measured since IRF3 recently has been implicated in virus-induced expression of the IFNβ gene Sato et al., 1998; Schafer et al., 1998; Wathelet et al., 1998; Yoneyama et al., 1998) . IRF7 mRNA was highly induced by virus infection in wild-type cells ( Figure 3A, lanes 7-12) . In contrast, IRF7 RNA was undetectable in Stat1-/-cells and its expression was only slightly induced 12 h following virus infection ( Figure 3A, lanes 1-6) . Dilution analysis demonstrated a Ͼ100-fold difference in IRF7 RNA levels between wild-type and Stat1-/-cells 10 h p.i. (not shown), the time of maximal IFN production (see Figures 1  and 2) . Similarly, IRF7 expression was not significantly induced by virus infection of IFNAR-/-cells (data not shown), suggesting that induction of this transcription factor in response to virus infection is largely dependent on autocrine production of IFN. Expression of IRF3 RNA was equal in wild-type and Stat1-/-cells and was unaffected by virus induction. Therefore, it is unlikely that this member of the IRF family is responsible for the IFN and Stat1 sensitivity of delayed-early IFN gene expression. Likewise, IRF1, which was also induced by IFN in a Stat1-dependent manner Meraz et al., 1996) , is unlikely to be involved based on results from IRF1-/-mice (Matsuyama et al., 1993; Reis et al., 1994) .
A human homolog of IRF7 previously was suggested to act as a repressor of Epstein-Barr virus (EBV) gene expression (Nonkwelo et al., 1997; Zhang and Pagano, 1997) . To test whether IRF7 is responsible for induction of IFNα genes, its ability to induce IFNα4 and IFNα6 promoter-reporter constructs was tested by co-transfection. Induction of these constructs by co-transfection of the related protein IRF3 was also measured ( Figure 3B ). Reporter constructs containing the IFNα4 promoter were activated 4-fold by NDV infection following co-transfection with IRF3 in 293T cells. However, the IFNα6 promoter was insensitive to IRF3 co-transfection. In contrast, both IFNα4 and IFNα6 promoters responded to cotransfected IRF7, and this induced gene expression was enhanced further in response to virus infection. Thus, the IFNα6 promoter appears to be insensitive to expression of IRF3, a factor that is constitutively expressed in both wild-type and Stat1-/-cells. However, IFNα6 expression was strongly enhanced by expression of IRF7, the IRF member induced only in wild-type infected cells and expressed in a manner parallel to that of the non-IFNα4 group.
The virus-independent activity of IRF7 observed with IFN promoter-reporter constructs may be due to the high levels of expression achieved in transfected 293T cells using replicating expression plasmids. The ability of IRF7 expression to rescue the non-IFNα4 induction defect of Stat1-/-cells was tested by transfection of non-replicating expression plasmids and measurement of endogenous gene expression ( Figure 4B ). For comparison, the levels of total IFNα production as well as IFNβ production were monitored in cells transfected with either IRF3 or IRF7. Transfection of IRF3 expression constructs had no detectable effect on IFN gene expression in response to NDV infection ( Figure 4B , compare lanes 2 and 4), nor did transfection of an N-terminally truncated form of IRF7 (IRF7D5Ј) that failed to bind DNA (not shown). However, transfection of full-length IRF7 strongly activated non-IFNα4 gene expression in NDV-infected, Stat1-/-cells ( Figure 4B , lane 6), restoring non-IFNα4 production to levels comparable with wild-type cells ( Figure 4B the non-IFNα4 genes. In response to virus infection, both IRF7 expression and its activation were necessary for full transactivation. The virus infection-independent action of IRF7 may signify that the activation event mediated by virus is also partially mimicked by the transfection process, as has been observed for activation of Stat pathways (Pine et al., 1988) , since both constitutive and infectiondependent activity were eliminated by identical point mutations (see below).
C-terminal serine residues are required for IRF7 activation by virus
It has been shown recently that activation of the IFNβ promoter by IRF3 requires a virus-induced serine phosphorylation in a C-terminal region Yoneyama et al., 1998) . Since the C-terminus of IRF7 is serine and threonine rich, we considered whether a similar modification may occur on IRF7. We expressed a truncated form of IRF7 lacking the final 34 amino acids in Stat1-/-cells ( Figure 4C ). Ectopic expression of this altered IRF7 construct failed to rescue non-IFNα4 gene expression in response to virus infection (lane 6) although the altered construct produced a stable protein (not shown). Although IRF7 and IRF3 are only 19% identical outside the DNAbinding region (Nguyen et al., 1997) , IRF7 contains two serine residues (amino acids 425 and 426) in similar sequence context to the two serine residues of IRF3 shown to be essential for its virus-induced activity (Yoneyama et al., 1998) . Therefore, we mutated these two residues in the context of full-length IRF7 and ectopically expressed this protein in Stat1-/-cells. Again, this altered IRF7 was incapable of rescuing the induction of the non-IFNα4 subtypes in response to NDV infection, nor did it affect basal IFNα gene expression. The mutant forms of IRF7 also failed to affect IFN promoter-luciferase reporters, suggesting that both basal and induced transactivation require IRF7 serine phosphorylation (not shown).
Further evidence of virus-induced, serine phosphorylation was indicated by IRF7 electrophoretic mobility. A high level of expression of epitope-tagged IRF7 and serine-mutant IRF7 was achieved in 293T cells, allowing direct detection of the proteins by Western blotting. IRF7 was expressed with and without NDV infection, and protein extracts were analyzed with an antibody to the epitope tag ( Figure 4D ). Wild-type protein exhibited a distinct mobility shift in response to virus infection ( Figure  4C , lane 2) which was reversed by phosphatase treatment (not shown), indicative of protein phosphorylation. In contrast, serine-mutant IRF7 did not display a mobility shift when isolated from either uninfected or virus-infected cells ( Figure 4C, lanes 3 and 4) . The small fraction of protein that underwent phosphorylation in these experiments probably results from the relative inefficiency of infection of 293T cells, and we were unable to reliably detect IRF7 protein in transfected embryo fibroblasts due to poorer transfection efficiencies and lower expression levels. However, these results strongly suggest that viral induction of the non-IFNα4 genes requires two changes in IRF7 protein: induction of increased protein abundance (an IFN-and Stat1-dependent event) and protein phosphorylation (a virus infection-dependent event).
Discussion
The above results demonstrate that the mouse IFNα genes are regulated differentially in virus-infected cells. Although it had been noted previously that IFNα genes are not all regulated in the same manner, most attention has been paid to comparisons of IFNα4, which is strongly induced by virus, and IFNα11, which is poorly inducible (Pitha and Au, 1995) . We show here that the IFNα4 gene is induced rapidly and directly in response to virus infection while other IFNα subtypes such as α2, α5, α6 and α8, although also induced, are expressed in a delayed manner that is dependent on protein synthesis. The protein synthesis-dependent character of the delayed genes results from a requirement for abundant IRF7 accumulation which in turn is dependent on transcriptional induction in response to early IFN synthesis and secretion.
Differential regulation of early and late genes
A model for IFNα gene regulation is illustrated in Figure  5 . It has been shown recently that the IFNβ gene, which like the IFNα4 gene is induced in a rapid and direct manner (Maniatis et al., 1987) , requires virus-induced modification of the pre-existing transcription factor IRF3 Sato et al., 1998; Schafer et al., 1998; Wathelet et al., 1998; Yoneyama et al., 1998) . The IRF3 transcription factor may also target other virus-induced cellular genes (Weaver et al., 1998) . By analogy, we suggest that the IFNα4 gene may be regulated similarly by virus-activated IRF3 ( Figure 5A ) which becomes phosphorylated, transported to the nucleus and engaged in a productive enhanceosome at the IFNα4 and IFNβ promoters in virus-infected cells. The IFNα4 promoter probably relies on IRF3 for induction while the IFNα6 promoter is unresponsive even to ectopically expressed IRF3 ( Figure 3B ), suggesting that IRF3 alone is insufficient to induce this gene. Activation of these immediate-early IFNα4 and IFNβ promoters would lead to production and secretion of type I IFN.
IFNα4 and/or IFNβ secreted from virus-infected cells during the early response would subsequently feed back on the cells through the type I IFN receptor ( Figure  5B ), stimulating the Jak-Stat pathway to activate the heteromeric transcription factor complex ISGF3 (Levy, 1995) . Loss of either the receptor, as in IFNAR-/-cells ( Figure 2C) , or of Stat1, as in Stat1-/-cells (Figure 1) , abrogates this loop. Active ISGF3 may play two roles in induction of the delayed, non-IFNα4 genes. First, it may bind directly to PRDI-like elements in these promoters, leading to gene activation, as was suggested for induction of IFNβ (Harada et al., 1996; Yoneyama et al., 1996) . Secondly, it probably binds to an ISRE sequence in the IRF7 promoter, leading to up-regulation of IRF7 production. Transcription and translation of the IRF7 gene would then lead to abundant IRF7 protein capable of binding to non-IFNα4 promoters and, following virusactivated phosphorylation, stimulating their activity ( Figure 5C ). Newly synthesized IRF7 may augment transcription of IFNβ and IFNα4 genes further. However, its activity is dependent on serine phosphorylation, a virusinduced event; therefore, its action is limited to virusinfected cells. This cascade of events would lead to the robust production of type I IFN secreted in response to virus infection.
Recently, it was reported that targeted disruption of the IFNβ locus led to impaired expression of IFNα genes in embryonic fibroblasts infected with Sendai virus (Erlandsson et al., 1998) . This result would suggest that IFNβ rather than IFNα4 plays an essential role in priming cells for the subsequent induction of IFNα genes. Why no IFNα4 was detected in this analysis is unclear. Differences due to mouse strain backgrounds, induction by Sendai rather than NDV or the sensitivity of the immunoassay employed for measuring IFNα production may account for the distinct results in our study. Indeed, IFNα gene expression induced in Stat1-/-cells was Ͻ1% of that detected in wild-type cells (Figure 1 ) which may score as background by immunoassay.
It has been suggested that IRF3 and IRF7 interact and function cooperatively at the human IFNβ promoter (Wathelet et al., 1998) . Whether IRF3 is also required along with IRF7 for activation of the non-IFNα4 promoters as well as of IFNα4 remains to be determined. It has been reported recently that IRF3 is degraded rapidly in virusinfected cells Ronco et al., 1998) , resulting in the depletion of IRF3 protein at the time when IRF7 and the delayed IFNα genes are being induced. Therefore, it is possible that IRF7 is the only IRF protein available for induction of the non-IFNα4 subset, probably cooperating with other promoter-bound factors (Au et al., 1993; Genin et al., 1995) . Similarly, it would appear from the inducibility of IFNα4 and IFNβ in Stat1-/-cells early following virus infection when IRF7 RNA is undetectable that IRF7 may be dispensable for expression of the immediate-early IFN genes. Indeed, IRF7 is expressed at very low levels prior to infection even in wild-type cells ( Figure 3A) , and ectopic expression of IRF7 has only a modest effect on IFNα4 and IFNβ gene induction although it is essential for expression of the non-IFNα4 subset (Figure 4) . While it is possible that the low levels of IRF7 present prior to infection are sufficient to cooperate with the abundant IRF3 and may be responsible for the higher levels of IFNα4 expressed by wild-type cells, our results are consistent with the notion that IRF7 is not absolutely necessary for IFNα4 or IFNβ induction while it is indispensable for expression of the non-IFNα4 genes. Whether IRF3 is required for induction of the non-IFNα4 subset remains to be determined.
The potential dual role of ISGF3 is more complex. As previously suggested, ISGF3 may bind and activate type I IFN promoters (Yoneyama et al., 1996) , and such an activity could explain our finding that non-IFNα4 genes could be induced in virus-infected cells in the absence of protein synthesis by addition of exogenous IFN ( Figure  2D ). An alternative explanation for IFN rescue of CHX inhibition is that translation of IRF7 might be relatively resistant to CHX treatment, and thus the added IFN stimulated production of sufficient IRF7 to mediate IFNα late gene expression in response to NDV under the conditions employed. Discrimination between these two possibilities will require an antibody capable of detecting production of IRF7. In either case, ISGF3 alone is not sufficient to activate type I IFN promoters, since no gene expression was induced by IFN in the absence of virus infection in spite of robust activation of IFN-stimulated genes, including IRF7. Therefore, if ISGF3 is capable of functioning at IFNα promoters, it does not act alone and additional virus-dependent factors or activation events must also be required.
Phosphorylation of IRFs
IRF7 is regulated in two ways. It is synthesized in response to IFN and it is activated by phosphorylation in virusinfected cells. The similarity of the phosphorylation site on IRF7 to a virus-dependent phosphorylation site on IRF3 suggests that these two proteins may be phosphorylated by the same or a similar kinase. However, the kinase(s) responsible for this modification is yet to be identified.
One potential kinase would be the double-stranded RNAdependent protein kinase, PKR. IFN induction is sensitive to the PKR inhibitor, 2-aminopurine (Zinn et al., 1988) . However, disruption of the gene for PKR does not prevent IFN induction in response to virus (Yang et al., 1995) , making it unlikely that PKR is required for this process. Consistent with the lack of requirement for PKR, we found induction of both IFNα4 and the non-IFNα4 gene subset in PKR-null cells infected with NDV (data not shown).
Another candidate kinase would be the IκB kinase since NFκB is also activated in virus-infected cells in a serine phosphorylation-dependent manner (Lenardo et al., 1989; Maniatis, 1997) , and we have found that the cytokineinduced IKKα kinase (DiDonato et al., 1997; Mercurio et al., 1997; Regnier et al., 1997; Woronicz et al., 1997; Zandi et al., 1997 ) is activated in virus-infected cells (data not shown). However, the phosphorylation site on IRF7 does not appear related to the induced phosphorylation sites on IκB, and we have been unable to observe IRF7 phosphorylation by IKKα in vitro (data not shown).
Multiple type I IFN genes
The physiological significance of the large number of IFNα genes has remained obscure. One possibility highlighted by the present results is that multiple genes allow distinct patterns of regulation. The IFNα4 and IFNβ genes may have evolved to provide an immediate response to virus infection, while the sequential induction of delayed genes provides a means of greatly amplifying the protective response to virus. It is possible that an effective response to acute infection requires higher levels of IFN production than can be achieved by expression from a single gene. In addition, some viruses are less effective inducers of IFN than NDV, and the amplification process afforded by IFN feedback may be particularly important for defense against such viruses.
Sequential activation of IFN genes could provide very tight control since a continuous signal from virus infection is required in addition to IRF7 protein induction. Thus, if the initial burst of IFNα4 and IFNβ production successfully eliminated infection, no further IFN would be produced since the newly synthesized IRF7 would be inactive without further modification. In fact, human IRF7 has been suggested as a possible repressor involved in EBV latency (Nonkwelo et al., 1997; Zhang and Pagano, 1997) . Perhaps in the absence of a specific activation event, the presence of non-phosphorylated IRF7 could compete for activator proteins. However, cells that were continuously or subsequently infected after IRF7 induction would be primed to continue IFN production because IRF7 would become phosphorylated.
The type I IFN gene family is tandemly arrayed on a single chromosome, and this gene cluster has been conserved throughout mammalian evolution (Nadeau et al., 1986; De Maeyer and De Maeyer-Guignard, 1988) . A potential pressure maintaining gene clustering could be to retain global regulation. IRF3 interacts with the histone acetylase p300 (Sato et al., 1998; Wathelet et al., 1998; Weaver et al., 1998; Yoneyama et al., 1998) . It is possible that recruitment of p300 to the IFNβ gene by IRF3 results in remodeling of the entire IFN gene locus, making the IFNα genes more accessible to transcription factors, such as IRF7. Such global control of tandemly linked genes could provide a strong evolutionary pressure to retain the linked IFN gene complex.
Materials and methods
Cells culture, transfections and viral infections
Immortalized embryo fibroblasts were derived from wild-type, Stat1-/- , IFNAR-/-(van den Broek et al., 1995) and IFNγ-/-embryos (Dalton et al., 1993) , as described (Todaro and Green, 1963) , and were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum. 293T and Cos cells were grown under the same conditions. DNA transfections of 293T, Cos and mouse fibroblasts were performed by standard methods using calcium phosphate. Stable cell lines of Stat1-/-fibroblasts reconstituted either with Stat1α or Stat1β were obtained by co-transfections using expression constructs in which the appropriate cDNA, originally cloned from a mouse brain library (Raz et al., 1994) , was driven by a cytomegalovirus immediate-early promoter, along with the pSV2pac selectable marker, followed by selection in medium containing 10 μg/ml of puromycin. Individual clones demonstrating responsiveness to IFN were obtained by fluorescence-activated cell sorting of IFN-treated cells using antibody M1/42.3 (ATCC) against MHC class I antigens. Expression of Stat1α and Stat1β was scored by Western blot using an antibody directed against the mouse Stat1 SH2 domain (Zymed Laboratories).
For viral infections, an NDV, Manhattan (Lee BioMolecular) was suspended at 108 p.f.u./ml in medium containing 0.1% bovine serum albumin (BSA), added to cell monolayers for 1 h at 37°C, and replaced with normal growth medium for 8 h, unless otherwise indicated. Where indicated, cells were treated with type I IFN (Lee BioMolecular) at 500 U/ml or type II IFN (Life Technology) at 5 ng/ml. Epitope-tagged versions were prepared by fusing a sequence encoding the FLAG peptide (Kodak) to the C-terminus. IRF3 was cloned into the NotI and XhoI sites of pBPSRT1 and IRF7 was cloned into the KpnI and XbaI sites of pcDNA3. N-and C-terminal deletion mutants of IRF7, IRF7Δ5Ј (IRF7 ) and IRF7Δ3Ј (IRF7 1-423 ) were designed by PCR and reintroduced into the full-length cDNA using a unique internal BstEII site and a flanking cloning site. The double point mutation at serine residues 425 and 426 of IRF7 (IRF7SSAA) was introduced into the full-length IRF7 using standard methods (Deng and Nickoloff, 1992) .
Plasmid constructs
Reporter constructs α4-Luc and α6-Luc were obtained by substituting the SV40 promoter of pGL3-Promoter (Promega) with the promoter regions of the IFNα4 or IFNα6 gene. PCR-generated fragments from mouse genomic DNA encoding -476 to ϩ10 and -432 to ϩ22 relative to the initiation site of IFNα4 and IFNα6, respectively, were cloned into the SmaI and NcoI sites of the vector. Luciferase activities were measured in cell lysates using commercial reagents as recommended by the manufacturer (Promega) and were normalized to the β-galactosidase activity of a co-transfected RSV-lacZ plasmid measured on a luminescent substrate (Tropix).
Expression analysis
Western blots were performed by standard methods using an anti-FLAG antibody (Kodak). RT-PCR was performed by standard protocols using total RNA and the following primers: (i) IFNα (consensus primers annealing with all IFNα subtypes) sense 5Ј-ATGGCTAGRCT-CTGTGCTTTCCT-3Ј, antisense 5Ј-AGGGCTCTCCAGAYTTCTGCT-CTG-3Ј; (ii) non-IFNα4 (5Ј primer fails to bind IFNα4 gene) sense 5Ј-ARSYTGTSTGATGCARCAGGT-3Ј, antisense 5Ј-GGWACACA-GTGATCCTGTGG-3Ј; (iii) IFNβ sense 5Ј-CATCAACTATAAGCAG-CTCCA-3Ј, antisense 5Ј-TTCAAGTGGAGAGCAGTTGAG-3Ј; (iv) GAPDH sense 5Ј-ACCACAGTCCATGCCATCAC-3Ј, antisense 5Ј-TCCACCACCCTGTTGCTGTA-3Ј; (v) IRF3 sense 5Ј-CCAGGTCTT-CCAGCAGACACT-3Ј, antisense 5Ј-TAGGCTGGCTGTTGGAGATGT-3Ј; (vi) IRF7 sense 5Ј-CAGCGAGTGCTGTTTGGAGAC-3Ј, antisense 5Ј-AAGTTCGTACACCTTATGCGG-3Ј.
To estimate relative amounts of specific RNA species, PCRs were performed on serially diluted samples of reverse transcription products, as described (Erlandsson et al., 1998) . For sequence analysis of IFNα gene expression, cDNA fragments were amplified by RT-PCR using the IFNα consensus primers, cloned into plasmid vectors, and 19 random clones from wild-type cells and 18 random clones from Stat1-/-cells were sequenced by standard methods.
